Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Allergan
Allergan
Page 4 of 6
Finance
Pfizer Says No Merger Tax Help For Our Top Execs
By
Dan Primack
November 25, 2015
Leadership
Pfizer’s CEO Isn’t a Hero or a Villain
By
Geoff Colvin
November 25, 2015
Finance
Pfizer’s Allergan Deal is an Even Bigger Tax Dodge Than It’s Claiming
By
Stephen Gandel
November 24, 2015
Finance
Investors Aren’t Convinced the Pfizer-Allergan Deal is a Go
By
Stephen Gandel
November 23, 2015
Finance
Will the Pfizer Inversion Get It Booted From the Dow?
By
Chris Matthews
November 23, 2015
Finance
Pfizer/Allergan deal pushes 2015 into the record books
By
Dan Primack
November 23, 2015
Health
Prediction: Healthcare’s M&A Flood Will Ebb in 2016
By
Jen Wieczner
November 23, 2015
Health
Pfizer, Allergan Confirm $160 Billion Merger Deal
By
Geoffrey Smith
and
Claire Groden
November 23, 2015
Leadership
Pfizer, Allergan Poised for $150 Billion Merger
By
Claire Groden
November 22, 2015
Finance
Why New Tax Inversion Rules Won’t Stop Pfizer-Allergan Deal
By
Stephen Gandel
November 20, 2015
Leadership
Will Lobbying Dollars Put Pfizer and Allergan On The Fast Track?
By
Paul Hodgson
November 20, 2015
Finance
Why Pfizer Is Headed for Splitsville After Allergan Merger
By
Jen Wieczner
November 19, 2015
Leadership
A Pfizer Deal With Allergan Would Add Fuel to the Fight Over Taxes
By
Alan Murray
November 19, 2015
Finance
Why Mylan Just Lost The Largest Hostile Takeover Battle Ever
By
Jen Wieczner
November 13, 2015
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By
Reuters
November 11, 2015
Most Popular
Success
The scientist who helped create AI says it’s only ‘a matter of time’ before every single job is wiped out—even safer...
By
Orianna Rosa Royle
Economy
James Talarico says the biggest 'welfare queens' in America are 'the giant corporations that don't pay a penny in...
By
Dave Smith
Success
As graduates face a ‘jobpocalypse,’ Goldman Sachs exec tells Gen Z they need to know their commercial impact
By
Preston Fore